head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2023, vol. 29, issue1
Subject Area: Medicine
DOI: 10.5272/jimab.2023291.4810
Published online: 13 February 2023

Original article
J of IMAB. 2023 Jan-Mar;29(1):4810-4813
Konstantin D. Gospodinov1ORCID logo Corresponding Autoremail, Yoana M, Todorova1ORCID logo, Nadia Stancheva1ORCID logo, Pavlina Glogovska2ORCID logo, Snezhanka T. Tisheva1ORCID logo,
1) Department of Cardiology, Sector Internal Medicine, UMHAT "Dr Georgi Stranski", Medical Faculty, Medical University Pleven, Bulgaria.
2) Department of Pulmonology, Sector Internal Medicine, UMHAT "Dr Georgi Stranski", Medical Faculty, Medical University Pleven, Bulgaria.

Heart failure (HF) is the final syndrome in the evolution of many heart diseases. Chronic obstructive pulmonary disease (COPD) syndrome is an important part of the clinical evolution of many parenchymal and vascular lung diseases. It is known that the downward curve of HF evolution and survival is being broken by many cardiac and non-cardiac comorbidities. Very often, there are patients who suffer from both heart and lung disease.
The aim of our study was to find out whether COPD has an impact on morbidity, mortality rate and life quality of patients with diagnosed heart failure.
The study comprised 256 patients admitted into our cardiology clinic in the period February 2014 –23rd of December, 2015. The patients were included depending on whether they comply or don't with certain criteria. They are divided into groups:  HF with COPD and HF without COPD, as well as into functional classes (FC).
Quite often, COPD coexists with HF, and they do share several risk factors. Patients with HF belonging to 2nd and 3rd FC and patients with COPD have relatively lower survival level and higher mortality level than patients only with HF in the same FC. Greater collaboration between cardiologists and pulmonologists is necessary in order to identify and manage  HF and COPD at the same time.

Keywords: Heart failure, COPD, survival rate, mortality rate, sex,

pdf - Download FULL TEXT /PDF 730 KB/
Please cite this article as: Gospodinov KD, Todorova YM, Stancheva N, Glogovska P, Tisheva ST. Does chronic obstructive pulmonary disease affect the clinical course of heart failure? J of IMAB. 2023 Jan-Mar;29(1):4810-4813. DOI: 10.5272/jimab.2022281.4810

Corresponding AutorCorrespondence to: Konstantin Dimitrov Gospodinov, Department of Cardiology, Medical Faculty, Medical University – Pleven; 8A, Georgi Kochev Str., 2nd. Floor, Pleven, Bulgaria; E-mail: drkdg@abv.bg

1. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, et al. Impact of non-cardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012 Mar 13;59(11):998-1005. [PubMed]
2. Baker JG, Wilcox RG. β-Blockers, heart disease and COPD: current controversies and uncertainties. Thorax. 2017 Mar;72(3):271-276. [PubMed]
3. De Blois J, Simard S, Atar D, Agewall S, Norwegian Heart Failure Registry. COPD predicts mortality in HF: the Norwegian Heart Failure Registry. J Card Fail. 2010 Mar;16(3):225-9. [PubMed]
4. Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF Jr, et al. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004 Dec;10(6):460-6. [PubMed]
5. Kaszuba E, Odeberg H, Råstam L, Halling A. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study. BMC Fam Pract. 2018 Nov 24;19(1):178. [PubMed]
6. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, et al. The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail. 2010 Jul;12(7):685-91. [PubMed]  
7. Macchia A, Monte S, Romero M, D'Ettorre A, Tognoni G. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalized for chronic heart failure. Eur J Heart Fail. 2007 Sep;9(9):942-8. [PubMed]
8. Rusinaru D, Saaidi I, Godard S, Mahjoub H, Battle C, Tribouilloy C. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol. 2008 Feb 1;101(3):353-8. [PubMed]
9. Pirina P, Martinetti M, Spada C, Zinellu E, Pes R, Chessa E, et al. Prevalence and management of COPD and heart failure comorbidity in the general practitioner setting. Respir Med. 2017 Oct;131:1-5. [PubMed]
10. Canepa M, Franssen FME, Olschewski H, Lainscak M, Böhm M, Tavazzi L, et al. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease. JACC Heart Fail. 2019 Oct;7(10):823-833. [PubMed].

Received: 06 October 2022
Published online: 13 February 2023

back to Online Journal